ACE inhibitors, aldosterone receptor blockers, and beta blockers could potentially prevent hypokalemia by opposing the neurohumoral activation associated with HF that lowers serum-[K+] (Macdonald and Struthers, 2004). The gene discussed is NR3C2; the disease is Hypokalemia.